The site will focus on producing essential hormones, including oestrogen gel and progesterone capsules, with two new dosages - 300 mg and 400 mg - to help meet the specific needs of patients.
The factory is 9,800 m², with the capacity to produce 25 million soft capsules and 10 million units of gel, increasing our production capabilities by 30%. Plus, it has created over 40 high-skilled job opportunities in Spain.
New, state-of-the-art manufacturing plant in Spain
We are excited to announce our brand new, state-of-the-art factory in Muel, Spain. This new facility has been designed to expand our production capabilities and cater to the growing demand for our high-quality healthcare products.
9,800m2
Site
~ 35M
Scaled to 35 million units sold annually
2023